Bone and joint pain are some of the most common side effects of aromatase inhibitors, medicines for hormone receptor-positive breast cancer. The official name for this is aromatase inhibitor associated — or sometimes induced — musculoskeletal syndrome, also called AIMSS. Many people report pain in the knees, ankles, and hips while taking an aromatase inhibitor, but the hands and the wrists also might be affected.

Hand expert Dr. David Bozentka discusses how AIMSS can affect the wrists and hands, including symptoms such as carpal tunnel syndrome, trigger finger, and tendonitis.

Listen to the episode to hear Dr. Bozentka explain:

the theories why aromatase inhibitors cause joint and bone pain, or AIMSS

how to decrease the risk of AIMSS

how carpal tunnel syndrome, trigger finger, and tendonitis are treated

This bonus episode is the audio from a Breastcancer.org webinar.

Follow-up care after breast cancer is essential. Getting good follow-up care can make a big difference in your long-term health and quality of life. In this Breastcancer.org webinar, you’ll find out how often you should see your oncologist after your treatment ends and get other practical advice from our expert panelists and patient advocates.

Watch the webinar to get expert advice from the panelists, including: 

Marisa C. Weiss, MD
Chief Medical Officer and Founder, Breastcancer.org

Hoda Badr, PhD
Professor, Department of Medicine, Baylor College of Medicine

Fumiko Chino, MD
Radiation Oncologist, Memorial Sloan Kettering Cancer Center

Evelyn Robles-Rodríguez, DNP, APN, AOCN
Director of Outreach, Prevention, and Survivorship, MD Anderson Cancer Center at Cooper

Erin Roesch, MD
Breast Medical Oncologist, Cleveland Clinic

Megan-Claire Chase
Breast Cancer Program Director, SHARE Cancer Support
Patient Advocate

Amanda Helms
Patient Advocate

Kate Rosenblum
Patient Advocate

Loriana Hernandez-Aldama
Two-Time Cancer Survivor, Award-winning Journalist, Author

The CHALLENGE trial found that a three-year, structured exercise program after chemotherapy for stage III colon cancer reduced the risk of the cancer coming back (recurrence risk) and also led to people living longer overall. Dr. Kerry Courneya, the lead researcher, thinks the results can be applied to people with other types of cancer, including breast cancer.

Listen to the episode to hear Dr. Courneya explain:

This podcast is the audio from a Breastcancer.org ⁠webinar⁠.

Many people struggle with intimacy during and after breast cancer treatment, but not everyone knows what to expect or how to manage these issues. Watch this webinar to learn about the physical and emotional challenges, and suggestions to improve sexual health.

The featured speakers are Marisa Weiss, MD, Jennifer Barsky Reese, PhD, FSBM, and Kristin Emilia Rojas, MD, FACS.

The topics they discuss include:

In the webinar you will also hear about the importance of discussing sexual health with healthcare providers, different methods and treatments to improve sexual health after breast cancer, the role of counseling and communication in dealing with these issues, and how exercise and lifestyle changes can help.

Learn more about sexual health and breast cancer.

This podcast is the audio from a Breastcancer.org webinar.

In this candid conversation, Marisa Weiss, MD, Michele Ley, MD, FACS, Pamela Munster, MD, and Rachel Swart, MD, PhD share what they each experienced when they went from the role of healthcare provider to patient.

Despite their medical training, many years of helping patients, and deep knowledge about breast cancer, they too felt their life come to a screeching halt when they were diagnosed.

They spoke honestly about how they managed treatment decisions, returning to work, how the experience changed their interactions with their own patients, what everyone can learn about advocating for yourself, and much more. Their hope is that by sharing their stories, they can help others coping with the same challenges, and empower everyone affected by breast cancer.

Featured speakers:

Marisa Weiss, MD
Chief Medical Officer, Breastcancer.org

Michele Ley, MD, FACS
Board-Certified Breast Surgical Oncologist and Founder, Tucson Breast Health Specialists

Pamela Munster, MD
Director, Early Phase Clinical Trials Unit, Co-leader of the Center for BRCA Research, and Co-Leader, Molecular Oncology Program, University of California San Francisco

Rachel Swart, MD, PhD
Medical Oncology and Hematology, Arizona Oncology

At the 2025 San Antonio Breast Cancer Symposium, Dr. Ian Tattersall, an oncodermatologist, was part of a panel focusing on body image, hair loss, and skin health after breast cancer treatment.

Listen to the episode to hear Dr. Tattersall explain:

The 2025 San Antonio Breast Cancer Symposium featured four days filled with new research findings, poster presentations, and educational sessions. Marisa Weiss, MD, founder and chief medical officer of Breastcancer.org, offers her take on the top results.

Listen to the episode to hear Dr. Weiss explain:

At the 2025 San Antonio Breast Cancer Symposium, Justin Johnson, PhD, presented a poster detailing the final results from three groups of people in a phase I trial on a vaccine to prevent triple-negative breast cancer.

Listen to the episode to hear Dr. Johnson explain:

At the 2025 San Antonio Breast Cancer Symposium, Ann Partridge, MD, MPH, presented research on the Young, Empowered & Strong (YES) mHealth tool designed to better meet the emotional and physical health needs of young people who’ve received breast cancer treatment.

Listen to the episode to hear Dr. Partridge explain:

At the 2025 San Antonio Breast Cancer Symposium, Dr. Jun Mao, an integrative medicine specialist and licensed acupuncturist at Memorial Sloan Kettering Cancer Center, presented research showing that both real and sham acupuncture can help improve cognitive function in women treated for breast cancer. Sham acupuncture mimics real acupuncture, but no needles pierce the skin.

Listen to the episode to hear Dr. Mao explain: